{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:44Z","timestamp":1792787864971,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Heidelberg","id":[{"id":"https:\/\/ror.org\/013czdx64","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Periprosthetic joint infection (PJI) is a serious complication after total joint arthroplasty and the leading cause of revision surgery. Two-stage revision with prosthesis removal, radical debridement, and interim antibiotic-loaded bone cement (ALBC) spacers is the current gold standard. ALBC spacers provide high local antibiotic concentrations and maintain joint space, with articulating designs improving interim mobility. Antibiotic release depends on cement composition, antibiotic content, and surface area, but the impact of surface structure remains unclear. This study investigated how surface morphology and area affect gentamicin and vancomycin release from ALBC in vitro.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Copal G\u2009+\u2009V cement (2\u00a0g vancomycin, 0.5\u00a0g gentamicin per 43\u00a0g) was cast into standardized rectangular blocks according to DIN ISO 5833. A reference group without surface structuring and three groups with progressively increasing surface area and depth were analyzed. After polymerization, specimens were incubated in phosphate-buffered saline at 37\u00a0\u00b0C. Antibiotic release was measured at defined intervals over six weeks using chemiluminescence immunoassay (CLIA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Surface structuring resulted in a clear increase in cumulative antibiotic release, particularly for vancomycin, with a consistent relationship between surface enlargement and total elution. The greatest surface structuring led to the highest release levels. Gentamicin showed a similar but less pronounced response, with a notable increase only at the highest degree of surface enlargement. The initial burst release contributed substantially to overall elution, while later-phase release differences between groups were less marked.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Surface modification of PMMA cement influenced antibiotic elution in this in vitro experimental model, with increased surface depth resulting in enhanced vancomycin release. Gentamicin elution was less affected by surface geometry and showed significant improvement only with the greatest surface enlargement. These findings indicate that structured cement surfaces may influence local antibiotic release characteristics under controlled laboratory conditions. However, the clinical relevance of these surface modifications remains to be determined, as this study was limited to cement blocks incubated in phosphate-buffered saline and did not include a spacer, infection, or in vivo model. Further experimental and in vivo investigations are required to assess whether surface structuring can improve antibiotic delivery in clinically relevant settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-026-10454-3","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:33:19Z","timestamp":1789205599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of surface structuring on antibiotic elution from bone cement in two-stage revision for periprosthetic joint infection"],"prefix":"10.1186","volume":"27","author":[{"given":"Kevin","family":"Knappe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Schonhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Schenker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Trefzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Philippe","family":"Kretzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Jaeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"10454_CR1","unstructured":"James I, Huddleston I. MD, Annual Report 2024, in American Academy of Orthopaedic Surgeons - American Joint Replacement Registry. 2024, American Academy of Orthopaedic Surgeons: https:\/\/www.aaos.org\/registries\/publications\/ajrr-annual-report\/. p. 141."},{"issue":"3","key":"10454_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5312\/wjo.v14.i3.113","volume":"14","author":"MM Alrayes","year":"2023","unstructured":"Alrayes MM, Sukeik M. Two-stage revision in periprosthetic knee joint infections. World J Orthop. 2023;14(3):113\u201322.","journal-title":"World J Orthop"},{"issue":"8","key":"10454_CR3","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1097\/CORR.0000000000001243","volume":"478","author":"ME Dombrowski","year":"2020","unstructured":"Dombrowski ME, et al. A Low Percentage of Patients Satisfy Typical Indications for Single-stage Exchange Arthroplasty for Chronic Periprosthetic Joint Infection. Clin Orthop Relat Res. 2020;478(8):1780\u20136.","journal-title":"Clin Orthop Relat Res"},{"key":"10454_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jor.2020.12.021","volume":"23","author":"I Lazic","year":"2021","unstructured":"Lazic I, et al. Treatment options in PJI - is two-stage still gold standard? J Orthop. 2021;23:180\u20134.","journal-title":"J Orthop"},{"issue":"2","key":"10454_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0039-1697608","volume":"7","author":"A Rava","year":"2019","unstructured":"Rava A, et al. Hip Spacers in Two-Stage Revision for Periprosthetic Joint Infection: A Review of Literature. Joints. 2019;7(2):56\u201363.","journal-title":"Joints"},{"issue":"3","key":"10454_CR6","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s12178-018-9495-y","volume":"11","author":"RS Charette","year":"2018","unstructured":"Charette RS, Melnic CM. Two-Stage Revision Arthroplasty for the Treatment of Prosthetic Joint Infection. Curr Rev Musculoskelet Med. 2018;11(3):332\u201340.","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"9","key":"10454_CR7","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00264-015-2751-5","volume":"39","author":"I Vielgut","year":"2015","unstructured":"Vielgut I, et al. Two-stage revision of prosthetic hip joint infections using antibiotic-loaded cement spacers: When is the best time to perform the second stage? Int Orthop. 2015;39(9):1731\u20136.","journal-title":"Int Orthop"},{"issue":"1","key":"10454_CR8","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jbm.b.31281","volume":"90","author":"K Anagnostakos","year":"2009","unstructured":"Anagnostakos K, Kelm J. Enhancement of antibiotic elution from acrylic bone cement. J Biomed Mater Res B Appl Biomater. 2009;90(1):467\u201375.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"11","key":"10454_CR9","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1007\/s00264-023-05922-7","volume":"47","author":"A Lunz","year":"2023","unstructured":"Lunz A, et al. Enhanced antibiotic release from bone cement spacers utilizing dual antibiotic loading with elevated vancomycin concentrations in two-stage revision for periprosthetic joint infection. Int Orthop. 2023;47(11):2655\u201361.","journal-title":"Int Orthop"},{"issue":"1\u20132","key":"10454_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijpharm.2017.02.066","volume":"522","author":"FJ Parra-Ruiz","year":"2017","unstructured":"Parra-Ruiz FJ, et al. Development of advanced biantibiotic loaded bone cement spacers for arthroplasty associated infections. Int J Pharm. 2017;522(1\u20132):11\u201320.","journal-title":"Int J Pharm"},{"issue":"1","key":"10454_CR11","first-page":"11","volume":"8","author":"O Shahpari","year":"2020","unstructured":"Shahpari O, et al. The Use of Antibiotic Impregnated Cement Spacers in the Treatment of Infected Total Joint Replacement: Challenges and Achievements. Arch Bone Jt Surg. 2020;8(1):11\u201320.","journal-title":"Arch Bone Jt Surg"},{"issue":"10","key":"10454_CR12","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00113-015-0062-3","volume":"118","author":"I Flesch","year":"2015","unstructured":"Flesch I. [Augmentation with antibiotic-impregnated spacers in sepsis revision surgery]. Unfallchirurg. 2015;118(10):844\u201350.","journal-title":"Unfallchirurg"},{"issue":"12","key":"10454_CR13","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.1007\/s00402-021-04274-4","volume":"142","author":"A Lunz","year":"2022","unstructured":"Lunz A, et al. Quality of life, infection control, and complication rates using a novel custom-made articulating hip spacer during two-stage revision for periprosthetic joint infection. Arch Orthop Trauma Surg. 2022;142(12):4041\u201354.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"11","key":"10454_CR14","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1007\/s00264-017-3500-8","volume":"41","author":"D Marczak","year":"2017","unstructured":"Marczak D, et al. Two stage revision hip arthroplasty in periprosthetic joint infection. Comparison study: with or without the use of a spacer. Int Orthop. 2017;41(11):2253\u20138.","journal-title":"Int Orthop"},{"key":"10454_CR15","doi-asserted-by":"publisher","first-page":"4323518","DOI":"10.1155\/2018\/4323518","volume":"2018","author":"SP Boelch","year":"2018","unstructured":"Boelch SP, et al. Comparison of Elution Characteristics and Compressive Strength of Biantibiotic-Loaded PMMA Bone Cement for Spacers: Copal(R) Spacem with Gentamicin and Vancomycin versus Palacos(R) R\u2009+\u2009G with Vancomycin. Biomed Res Int. 2018;2018:4323518.","journal-title":"Biomed Res Int"},{"issue":"1","key":"10454_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1302\/0301-620X.99B1.BJJ-2016-0566.R1","volume":"99\u2013B","author":"NM Frew","year":"2017","unstructured":"Frew NM, et al. Comparison of the elution properties of commercially available gentamicin and bone cement containing vancomycin with \u2018home-made\u2019 preparations. Bone Joint J. 2017;99\u2013B(1):73\u20137.","journal-title":"Bone Joint J"},{"issue":"7","key":"10454_CR17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00113-017-0372-8","volume":"120","author":"KD Kuhn","year":"2017","unstructured":"Kuhn KD, Renz N, Trampuz A. [Local antibiotic therapy]. Unfallchirurg. 2017;120(7):561\u201372.","journal-title":"Unfallchirurg"},{"key":"10454_CR18","unstructured":"HeraeusMedical. COPAL\u00ae G\u2009+\u2009V \u2013 High-Viscosity Bone Cement with Gentamicin and Vancomycin. 2024; Available from: https:\/\/www.heraeus-medical.com\/en-us\/healthcare-professionals\/products\/copal-gv\/."},{"key":"10454_CR19","doi-asserted-by":"crossref","unstructured":"Schonhoff M et al. The Effect of Cement Aging on the Stability of a Cement-in-Cement Revision Construct. Appl Sciences-Basel. 2021;11(6):2814.","DOI":"10.3390\/app11062814"},{"issue":"1","key":"10454_CR20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1186\/s12891-022-05895-5","volume":"23","author":"A Lunz","year":"2022","unstructured":"Lunz A, et al. Mechanical strength of antibiotic-loaded PMMA spacers in two-stage revision surgery. BMC Musculoskelet Disord. 2022;23(1):945.","journal-title":"BMC Musculoskelet Disord"},{"issue":"3","key":"10454_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2106\/00004623-197658030-00011","volume":"58","author":"KE Marks","year":"1976","unstructured":"Marks KE, Nelson CL, Lautenschlager EP. Antibiotic-impregnated acrylic bone cement. J Bone Joint Surg Am. 1976;58(3):358\u201364.","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"10454_CR22","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2106\/00004623-197860070-00019","volume":"60","author":"DJ Schurman","year":"1978","unstructured":"Schurman DJ, et al. Antibiotic-acrylic bone cement composites. Studies of gentamicin and Palacos. J Bone Joint Surg Am. 1978;60(7):978\u201384.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"10454_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/jbm.820120509","volume":"12","author":"A Welch","year":"1978","unstructured":"Welch A. Antibiotics in acrylic bone cement. In vitro studies. J Biomed Mater Res. 1978;12(5):679\u2013700.","journal-title":"J Biomed Mater Res"},{"key":"10454_CR24","doi-asserted-by":"publisher","first-page":"290851","DOI":"10.5402\/2011\/290851","volume":"2011","author":"A Bistolfi","year":"2011","unstructured":"Bistolfi A, et al. Antibiotic-loaded cement in orthopedic surgery: a review. ISRN Orthop. 2011;2011:290851.","journal-title":"ISRN Orthop"},{"issue":"8","key":"10454_CR25","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1007\/s00590-023-03557-3","volume":"33","author":"D Cieremans","year":"2023","unstructured":"Cieremans D, et al. Does antibiotic bone cement reduce infection rates in primary total knee arthroplasty? Eur J Orthop Surg Traumatol. 2023;33(8):3379\u201385.","journal-title":"Eur J Orthop Surg Traumatol"},{"issue":"12","key":"10454_CR26","doi-asserted-by":"publisher","first-page":"e82745","DOI":"10.1371\/journal.pone.0082745","volume":"8","author":"J Wang","year":"2013","unstructured":"Wang J, et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS ONE. 2013;8(12):e82745.","journal-title":"PLoS ONE"},{"issue":"6","key":"10454_CR27","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cjtee.2022.06.001","volume":"25","author":"T Xu","year":"2022","unstructured":"Xu T, Wu KL, Jie K. Comprehensive meta-analysis of antibiotic-impregnated bone cement versus plain bone cement in primary total knee arthroplasty for preventing periprosthetic joint infection. Chin J Traumatol. 2022;25(6):325\u201330.","journal-title":"Chin J Traumatol"},{"issue":"1","key":"10454_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/infdis\/155.1.93","volume":"155","author":"RD Moore","year":"1987","unstructured":"Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987;155(1):93\u20139.","journal-title":"J Infect Dis"},{"issue":"5","key":"10454_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/qjmed\/95.5.291","volume":"95","author":"D Raveh","year":"2002","unstructured":"Raveh D, et al. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. QJM. 2002;95(5):291\u20137.","journal-title":"QJM"},{"issue":"12","key":"10454_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/qjmed\/hcp143","volume":"102","author":"NM Selby","year":"2009","unstructured":"Selby NM, et al. Gentamicin-associated acute kidney injury. QJM. 2009;102(12):873\u201380.","journal-title":"QJM"},{"issue":"2","key":"10454_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jiac.2020.09.033","volume":"27","author":"T Yamada","year":"2021","unstructured":"Yamada T, et al. A meta-analysis of the target trough concentration of gentamicin and amikacin for reducing the risk of nephrotoxicity. J Infect Chemother. 2021;27(2):256\u201361.","journal-title":"J Infect Chemother"},{"issue":"2","key":"10454_CR32","doi-asserted-by":"publisher","first-page":"8540","DOI":"10.4081\/or.2020.8540","volume":"12","author":"D Mazza","year":"2020","unstructured":"Mazza D, et al. Acute kidney failure after total knee arthroplasty revision with antibiotic-impregnated cement spacer. Orthop Rev (Pavia). 2020;12(2):8540.","journal-title":"Orthop Rev (Pavia)"},{"issue":"8","key":"10454_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s40262-022-01143-0","volume":"61","author":"CJ Hodiamont","year":"2022","unstructured":"Hodiamont CJ, et al. Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review. Clin Pharmacokinet. 2022;61(8):1075\u201394.","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10454_CR34","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1592\/phco.2005.25.6.876","volume":"25","author":"JM Curtis","year":"2005","unstructured":"Curtis JM, Sternhagen V, Batts D. Acute renal failure after placement of tobramycin-impregnated bone cement in an infected total knee arthroplasty. Pharmacotherapy. 2005;25(6):876\u201380.","journal-title":"Pharmacotherapy"},{"issue":"11","key":"10454_CR35","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1345\/aph.1H173","volume":"40","author":"BN Patrick","year":"2006","unstructured":"Patrick BN, Rivey MP, Allington DR. Acute renal failure associated with vancomycin- and tobramycin-laden cement in total hip arthroplasty. Ann Pharmacother. 2006;40(11):2037\u201342.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10454_CR36","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/j.arth.2016.11.042","volume":"32","author":"F Amerstorfer","year":"2017","unstructured":"Amerstorfer F, et al. Superficial Vancomycin Coating of Bone Cement in Orthopedic Revision Surgery: A Safe Technique to Enhance Local Antibiotic Concentrations. J Arthroplasty. 2017;32(5):1618\u201324.","journal-title":"J Arthroplasty"},{"key":"10454_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jor.2023.10.017","volume":"46","author":"AWR Burns","year":"2023","unstructured":"Burns AWR, et al. The use of intra-articular vancomycin is safe in primary hip and knee arthroplasty. J Orthop. 2023;46:161\u20133.","journal-title":"J Orthop"},{"issue":"8","key":"10454_CR38","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1002\/jor.20214","volume":"24","author":"PH Hsieh","year":"2006","unstructured":"Hsieh PH, et al. High concentration and bioactivity of vancomycin and aztreonam eluted from Simplex cement spacers in two-stage revision of infected hip implants: a study of 46 patients at an average follow-up of 107 days. J Orthop Res. 2006;24(8):1615\u201321.","journal-title":"J Orthop Res"},{"key":"10454_CR39","doi-asserted-by":"crossref","unstructured":"Salvati EA et al. Reimplantation in infection. Elution of gentamicin from cement and beads. Clin Orthop Relat Res. 1986(207):83\u201393.","DOI":"10.1097\/00003086-198606000-00015"},{"issue":"8","key":"10454_CR40","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/jor.24588","volume":"38","author":"MB Thomassen","year":"2020","unstructured":"Thomassen MB, et al. Local concentrations of gentamicin obtained by microdialysis after a controlled application of a GentaColl sponge in a porcine model. J Orthop Res. 2020;38(8):1793\u20139.","journal-title":"J Orthop Res"},{"key":"10454_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.blo.0000144476.43661.10","volume":"427","author":"BD Springer","year":"2004","unstructured":"Springer BD, et al. Systemic safety of high-dose antibiotic-loaded cement spacers after resection of an infected total knee arthroplasty. Clin Orthop Relat Res. 2004;427:47\u201351.","journal-title":"Clin Orthop Relat Res"},{"issue":"1","key":"10454_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s40001-023-01138-y","volume":"28","author":"F Migliorini","year":"2023","unstructured":"Migliorini F, et al. Bacterial pathogens and in-hospital mortality in revision surgery for periprosthetic joint infection of the hip and knee: analysis of 346 patients. Eur J Med Res. 2023;28(1):177.","journal-title":"Eur J Med Res"},{"issue":"3","key":"10454_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1056\/NEJMra2203477","volume":"388","author":"R Patel","year":"2023","unstructured":"Patel R. Periprosthetic Joint Infection. N Engl J Med. 2023;388(3):251\u201362.","journal-title":"N Engl J Med"},{"issue":"1","key":"10454_CR44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.arth.2020.07.020","volume":"36","author":"JM Villa","year":"2021","unstructured":"Villa JM, et al. International Organism Profile of Periprosthetic Total Hip and Knee Infections. J Arthroplasty. 2021;36(1):274\u20138.","journal-title":"J Arthroplasty"},{"issue":"16","key":"10454_CR45","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1056\/NEJMra040181","volume":"351","author":"W Zimmerli","year":"2004","unstructured":"Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351(16):1645\u201354.","journal-title":"N Engl J Med"},{"issue":"5","key":"10454_CR46","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1128\/AAC.03147-14","volume":"60","author":"R Alvarez","year":"2016","unstructured":"Alvarez R, et al. Optimizing the Clinical Use of Vancomycin. Antimicrob Agents Chemother. 2016;60(5):2601\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10454_CR47","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.cmi.2017.06.017","volume":"24","author":"R Diaz","year":"2018","unstructured":"Diaz R, et al. Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis. Clin Microbiol Infect. 2018;24(2):97\u2013104.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10454_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3109\/17453679308994537","volume":"64","author":"TS Sorensen","year":"1993","unstructured":"Sorensen TS, Sorensen AI. Bactericidal activity of gentamicin against S. aureus. In vitro study questions value of prolonged high concentrations. Acta Orthop Scand. 1993;64(1):82\u20134.","journal-title":"Acta Orthop Scand"},{"key":"10454_CR49","first-page":"63","volume":"74","author":"WA Craig","year":"1990","unstructured":"Craig WA, Ebert SC. Killing and regrowth of bacteria in vitro: a review. Scand J Infect Dis Suppl. 1990;74:63\u201370.","journal-title":"Scand J Infect Dis Suppl"},{"key":"10454_CR50","doi-asserted-by":"crossref","unstructured":"Dalton BR. What Is the Best Vancomycin Therapeutic Drug Monitoring Parameter to Assess Efficacy? A Critical Review of Experimental Data and Assessment of the Need for Individual Patient Minimum Inhibitory Concentration Value. Microorganisms. 2023;11(3):567.","DOI":"10.3390\/microorganisms11030567"},{"issue":"3","key":"10454_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13318-017-0456-4","volume":"43","author":"F Elbarbry","year":"2018","unstructured":"Elbarbry F. Vancomycin Dosing and Monitoring: Critical Evaluation of the Current Practice. Eur J Drug Metab Pharmacokinet. 2018;43(3):259\u201368.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"11","key":"10454_CR52","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1093\/jac\/dkw254","volume":"71","author":"ZK Ye","year":"2016","unstructured":"Ye ZK, et al. Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society. J Antimicrob Chemother. 2016;71(11):3020\u20135.","journal-title":"J Antimicrob Chemother"},{"key":"10454_CR53","doi-asserted-by":"crossref","unstructured":"Chen IC et al. Influence of Antibiotic-Loaded Acrylic Bone Cement Composition on Drug Release Behavior and Mechanism. Polym (Basel). 2021;13(14):2240.","DOI":"10.3390\/polym13142240"},{"issue":"8","key":"10454_CR54","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1080\/03639045.2020.1788058","volume":"46","author":"M Gandomkarzadeh","year":"2020","unstructured":"Gandomkarzadeh M, Mahboubi A, Moghimi HR. Release behavior, mechanical properties, and antibacterial activity of ciprofloxacin-loaded acrylic bone cement: a mechanistic study. Drug Dev Ind Pharm. 2020;46(8):1209\u201318.","journal-title":"Drug Dev Ind Pharm"},{"key":"10454_CR55","doi-asserted-by":"publisher","first-page":"111999","DOI":"10.1016\/j.msec.2021.111999","volume":"123","author":"LM Mensah","year":"2021","unstructured":"Mensah LM, Love BJ. A meta-analysis of bone cement mediated antibiotic release: Overkill, but a viable approach to eradicate osteomyelitis and other infections tied to open procedures. Mater Sci Eng C Mater Biol Appl. 2021;123:111999.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"4","key":"10454_CR56","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/jor.23722","volume":"36","author":"J Slane","year":"2018","unstructured":"Slane J, Gietman B, Squire M. Antibiotic elution from acrylic bone cement loaded with high doses of tobramycin and vancomycin. J Orthop Res. 2018;36(4):1078\u201385.","journal-title":"J Orthop Res"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-026-10454-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-10454-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-026-10454-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:03:04Z","timestamp":1791230584000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12891-026-10454-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10454"],"URL":"https:\/\/doi.org\/10.1186\/s12891-026-10454-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was a biomechanical experimental investigation and did not involve human participants, human or animal tissue, or the collection of patient data for research purposes. Therefore, according to the regulations of the Ethics Committee of the Medical Faculty of Heidelberg University, formal ethical approval was not required. The radiographic images presented were retrospectively retrieved from the institutional PACS system and fully anonymized. Written informed consent for publication of these images was obtained from the patient.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.J. receives support from Johnson & Johnson, DePuy Synthes\/Johnson & Johnson Medical GmbH, B. Braun Aesculap, Waldemar Link, Heraeus Medical, Zimmer Biomet, Peter Brehm GmbH, CeramTec, Implantcast, Medacta, Mathys, Tornier, Stryker, Kerimedical, Medartis, the BMBF \u2013 German Federal Ministry of Education and Research, Stiftung Endoprothetik, and Deutsche Arthrose Stiftung (German Osteoarthritis Foundation).J.P.K. receives or has received research grants and\/or institutional research support from the DFG (German Research Foundation), BMBF (German Federal Ministry of Education and Research), Ghent University, Stiftung Endoprothetik, Deutsche Arthrose Stiftung (German Osteoarthritis Foundation), AQ Solutions GmbH, CeramTec GmbH, Implantcast GmbH, Innoproof GmbH, SINTX Technologies, Inc., Permedica S.p.A., and Questmed GmbH. J.P.K. also receives or has received personal support, including consultancy, speaker honoraria, and\/or travel support, from Meril GmbH, Permedica S.p.A., Falcon Medical GmbH, DePuy Synthes\/Johnson & Johnson Medical GmbH, Verein zur F\u00f6rderung der Traumatologie und Endoprothetik e.V., and the Arbeitsgemeinschaft Endoprothetik (AE).The other authors declare no conflict of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"819"}}